BCL2 and diffuse large B-cell lymphoma: Despite the established role of BCL-2 as a predictor of chemoresistance in DLBCL, specific inhibition of its anti-apoptotic activity by the BH3-mimetic venetoclax showed low efficacy in the relapsed/refractory (r/r) setting.26